CTO) medical director. Cho will be responsible for overseeing the
UH Cancer Center’s clinical trials administered through
CTO. He has been a faculty member of the
UH Cancer Center since 1991, and has served the people of Hawaiʻi as a local oncologist for more than 29 years. Since 2016, the
UH Cancer Center has enrolled more than 16,000 patients in clinical trials in Hawaiʻi.
Cho is no stranger to clinical trials in Hawaiʻi, having been a strong advocate for clinical trials and enrolling many patients on
UH Cancer Center trials as a leading community oncologist. He led the
UH Cancer Center’s
CMO: First case of vaccine complication detected in Trinidad and Tobago newsday.co.tt - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.co.tt Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing.
MedPage Today. Doctors and people receiving the vaccine should be aware that ischemic stroke can be a sign of VITT, he said. Ischemic stroke as part of VITT needs to be recognized quickly because there are specific treatments, including immunoglobulins, plasma exchange, and anticoagulants, that can improve the outcome.
VITT is a rare syndrome associated with the AstraZeneca adenoviral vector vaccine, which uses a chimpanzee adenovirus-based vector. It is used in England and other countries but not the U.S. Cerebral venous sinus thrombosis also has been reported in people who received the Johnson & Johnson COVID-19 vaccine, which uses a human adenovirus-based vector.